labetalol and methyldopa

labetalol has been researched along with methyldopa in 90 studies

Research

Studies (90)

TimeframeStudies, this research(%)All Research%
pre-199028 (31.11)18.7374
1990's9 (10.00)18.2507
2000's11 (12.22)29.6817
2010's36 (40.00)24.3611
2020's6 (6.67)2.80

Authors

AuthorsStudies
Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL1
Lombardo, F; Obach, RS; Waters, NJ1
González-Díaz, H; Orallo, F; Quezada, E; Santana, L; Uriarte, E; Viña, D; Yáñez, M1
Chupka, J; El-Kattan, A; Feng, B; Miller, HR; Obach, RS; Troutman, MD; Varma, MV1
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A1
Choi, SS; Contrera, JF; Hastings, KL; Kruhlak, NL; Sancilio, LF; Weaver, JL; Willard, JM1
Campillo, NE; Guerra, A; Páez, JA1
García-Mera, X; González-Díaz, H; Prado-Prado, FJ1
Fisk, L; Greene, N; Naven, RT; Note, RR; Patel, ML; Pelletier, DJ1
Glen, RC; Lowe, R; Mitchell, JB1
Ekins, S; Williams, AJ; Xu, JJ1
Bellera, CL; Bruno-Blanch, LE; Castro, EA; Duchowicz, PR; Goodarzi, M; Ortiz, EV; Pesce, G; Talevi, A1
Annand, R; Gozalbes, R; Jacewicz, M; Pineda-Lucena, A; Tsaioun, K1
Chen, M; Fang, H; Liu, Z; Shi, Q; Tong, W; Vijay, V1
Ambroso, JL; Ayrton, AD; Baines, IA; Bloomer, JC; Chen, L; Clarke, SE; Ellens, HM; Harrell, AW; Lovatt, CA; Reese, MJ; Sakatis, MZ; Taylor, MA; Yang, EY1
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ1
Bellman, K; Knegtel, RM; Settimo, L1
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K1
Gifford, RW; Tarazi, RC; Wollam, GL1
Havard, CW; Pearson, RM1
Boakes, AJ; Prichard, BN1
Davies, DM; Gales, GM; Rao, JG; Rawlins, MD; Routledge, PA; Sanders, GL2
Lamming, GD; Symonds, EB1
Catto, GR; Edward, N; Gemmell, HG; Innes, A; Smith, FW1
Anderson, GD; Mabie, WC; Shamsa, F; Sibai, BM; Villar, MA1
Crawford, GA; Gallery, ED; Györy, AZ; Kelly, D1
Naden, RP; Redman, CW1
Ariëns, EJ; Mohr, K1
Durando, C; Gessa, M; Leidi, L; Maina, G; Margaria, E; Medaglia, M1
Materson, BJ1
Elghozi, JL; Meyer, P; Saad, MA1
Breart, G; Maillard, F; Papiernik, E; Plouin, PF; Relier, JP2
Vidt, DG1
Blazquez, G; Gérard, J; Lardoux, H; Leperlier, E1
Rasmussen, K1
Murnaghan, DJ; O'Hare, JA1
Prichard, BN; Richards, DA1
Lund-Johansen, P1
Wallin, JD1
Drayer, JI; Weber, MA1
Prichard, BN1
Broughton Pipkin, F; Jadoul, FA; Lamming, GD; Symonds, EM1
Langford, H; Maloy, J; Maronde, RF; Michelson, EL; Poland, M; Wallin, JD; Wilson, D; Winer, N1
Latham, L; Lorimer, AR; McAreavey, D; McLaren, AD; Ramsey, LE; Reid, JL; Robertson, JI; Robertson, MP; Weir, RJ1
Al-Damluji, SF; Al-Khalidi, A; Shaarbaf, H; Tawfiq, NH1
Clifton, G; Cruz, F; O'Neill, WM; Wallin, JD1
Broughton Pipkin, F; Lamming, GD; Symonds, EM1
Abassi, ZA; Cuda, G; Golomb, E; Keiser, HR; Panchal, VR; Stylianou, M; Trachewsky, D1
Connelly, JF; Zigmont, EA1
al-Fadly, A; el-Qarmalawi, AM; Hashem, M; Morsy, AH; Obeid, A1
Clairambault, J; Curzi-Dascalova, L; Eiselt, M; Kauffmann, F; Médigue, C; Peirano, P; Spassov, L1
al-Qattan, F; Makhseed, M; Omu, AE1
Braude, PR; Khalaf, Y; Midgley, DY; Nelson-Piercy, C1
Bolte, AC; Dekker, GA; van Geijn, HP1
Rollins, G1
Oparil, S; Rosenthal, T1
Dennedy, MC; Houlihan, DD; Morrison, JJ; Ravikumar, N1
Blasi, I; Facchinetti, F; Gori, GF; Jasonni, VM; Neri, I1
Malik, A; Shafi, NA; Silverman, DI1
Abdel-Hady, el-S; El-Negeri, M; Fawzy, M; Helal, AS; Nezar, M; Ragab, A1
Eskes, TK; Gabreëls, FJ; Pasker-de Jong, PC; Pellegrino, A; van Gelder, MM; Zielhuis, GA1
Borrajo Prol, MP; Bravo López, JJ; Iglesias Forneiro, A; Santos Nores, J1
Graham, DF; Hadlow, N; Oates, R; Tsokos, N1
Koucký, M1
Jabeen, F; Malik, AR; Mir, S; Molvi, SN; Rana, VS1
Alexander, JM; Wilson, KL1
Arulkumaran, N; Lightstone, L1
Bateman, BT; Ecker, JL; Fischer, MA; Hernandez-Diaz, S; Huybrechts, KF; Mogun, H; Palmsten, K; Seely, EW1
Guo, Y; Krewski, D; Mattison, D; Nerenberg, K; Walker, MC; Wen, SW; Xie, RH2
Charlton, F; Hennessy, A; Makris, A; Xu, B1
Firoz, T; Gordon, R; MacDonell, K; Magee, LA; Payne, BA; Vidler, M; von Dadelszen, P1
Chattopadhyay, S; Das, A; Pahari, S1
Gangooly, S; Jauniaux, E; Muttukrishna, S1
Asztalos, E; Gafni, A; Ganzevoort, JW; Gruslin, A; Helewa, M; Hutton, E; Koren, G; Lee, SK; Lee, T; Logan, AG; Magee, LA; Menzies, J; Moutquin, JM; Murphy, KE; Rey, E; Ross, S; Sanchez, J; Singer, J; Thornton, JG; von Dadelszen, P; Welch, R2
Sibai, BM1
Bobek, G; Hennessy, A; Makris, A; Xu, B1
August, P; Podymow, T1
Jim, B; Reddy, S1
Bracken, H; Easterling, T; Magee, LA; Mool, S; Mundle, S; Parvekar, S; Shochet, T; von Dadelszen, P; Winikoff, B1
Karumanchi, SA; Lemoine, ER1
Aboul-Enein, HY; Ali, I; ALOthman, ZA; Alsheetan, KM1
Badr, H; Dawood, R; El-Shamy, E; Emarh, M; Gamal, A; Masood, A; Rezk, M1
Alers, RJ; Cauffman, E; Ghossein-Doha, C; Lopes van Balen, VA; Mulder, EG; Oben, J; Schiffer, VMMM; Smits, L; Spaanderman, MEA; van Kuijk, SMJ1
Ashworth, D; Battersby, C; Chappell, LC; Cluver, C; Green, M; Hardy, P; McManus, RJ1
Avalos, LA; Badon, SE; Bider-Canfield, Z; Cheetham, TC; Chen, L; Dublin, S; Easterling, TR; Holt, VL; Idu, A; Nance, N; Neugebauer, RS; Reynolds, K; Shortreed, SM1
Allegaert, K; Flint, RB; Mian, P; Schoenmakers, S; van de Vusse, D; Versmissen, J; Visser, W1

Reviews

17 review(s) available for labetalol and methyldopa

ArticleYear
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
    Drug discovery today, 2016, Volume: 21, Issue:4

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk

2016
Antihypertensive drugs: clinical pharmacology and therapeutic use.
    Drugs, 1977, Volume: 14, Issue:6

    Topics: Adrenergic beta-Antagonists; Angiotensin II; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Clonidine; Diazoxide; Diuretics; Ganglionic Blockers; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Minoxidil; Monoamine Oxidase Inhibitors; Nitroprusside; Potassium; Prazosin; Secologanin Tryptamine Alkaloids; Sympatholytics

1977
Antihypertensive drugs in pregnancy.
    Clinics in perinatology, 1985, Volume: 12, Issue:3

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diazoxide; Diuretics; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Regional Blood Flow; Uterus

1985
[False stereochemical tracks in pharmacotherapy].
    Deutsche medizinische Wochenschrift (1946), 1985, Nov-08, Volume: 110, Issue:45

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Agonists; Drug Antagonism; Drug Combinations; Drug Synergism; Drug Therapy; Epinephrine; Humans; Kinetics; Labetalol; Methacholine Compounds; Methyldopa; Molecular Conformation; Optical Rotation; Stereoisomerism; Substrate Specificity; Terminology as Topic

1985
Adverse effects of antihypertensive treatment.
    Cardiology clinics, 1986, Volume: 4, Issue:1

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Enzyme Inhibitors; Humans; Hypertension; Labetalol; Methyldopa; Prazosin; Quality of Life; Sympatholytics; Vasodilator Agents

1986
Comparison of labetalol with other anti-hypertensive drugs.
    British journal of clinical pharmacology, 1982, Volume: 13, Issue:1 Suppl

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Diuretics; Drug Therapy, Combination; Ethanolamines; Hemodynamics; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa

1982
Central and peripheral blockade of the sympathetic nervous system.
    The American journal of medicine, 1984, Oct-05, Volume: 77, Issue:4A

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Guanabenz; Humans; Hypertension; Indoramin; Labetalol; Methyldopa; Prazosin; Quinazolines; Reserpine; Sympathetic Nervous System; Sympatholytics

1984
Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Drugs, 1984, Volume: 28 Suppl 2

    Topics: Administration, Oral; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Anesthesia; Antihypertensive Agents; Asthma; Blood Pressure; Clonidine; Diuretics; Drug Therapy, Combination; Ethanolamines; Female; Heart Failure; Humans; Hydralazine; Hypertension; Hypertension, Renal; Infusions, Parenteral; Kidney Failure, Chronic; Labetalol; Methyldopa; Parasympathetic Nervous System; Pheochromocytoma; Pregnancy; Pregnancy Complications, Cardiovascular; Substance Withdrawal Syndrome; Tetanus

1984
Pharmacological treatment of severe hypertension in pregnancy and the role of serotonin(2)-receptor blockers.
    European journal of obstetrics, gynecology, and reproductive biology, 2001, Volume: 95, Issue:1

    Topics: Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Diuretics; Female; Humans; Hypertension; Ketanserin; Labetalol; Methyldopa; Nitric Oxide Donors; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Receptors, Serotonin; Serotonin Antagonists

2001
The effect of antihypertensive drugs on the fetus.
    Journal of human hypertension, 2002, Volume: 16, Issue:5

    Topics: Adrenergic alpha-Agonists; Adrenergic beta-Antagonists; Angiotensin-Converting Enzyme Inhibitors; Antihypertensive Agents; Calcium Channel Blockers; Female; Fetus; Humans; Hypertension; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular

2002
[Current perspective of treating hypertension in pregnancy].
    Vnitrni lekarstvi, 2011, Volume: 57, Issue:9

    Topics: Antihypertensive Agents; Calcium Channel Blockers; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular

2011
Hypertensive emergencies of pregnancy.
    Obstetrics and gynecology clinics of North America, 2013, Volume: 40, Issue:1

    Topics: Antihypertensive Agents; Calcium Channel Blockers; Creatine; Diuretics; Emergency Medicine; Female; Fetal Monitoring; Humans; Hydralazine; Infusions, Intravenous; Labetalol; Methyldopa; Nifedipine; Nitroprusside; North America; Oliguria; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Proteinuria

2013
Severe pre-eclampsia and hypertensive crises.
    Best practice & research. Clinical obstetrics & gynaecology, 2013, Volume: 27, Issue:6

    Topics: Administration, Intravenous; Administration, Oral; Antihypertensive Agents; Critical Care; Early Diagnosis; Eclampsia; Female; HELLP Syndrome; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Nitroglycerin; Pre-Eclampsia; Pregnancy; Risk Assessment; Risk Factors; Severity of Illness Index; Treatment Outcome; United Kingdom

2013
Oral antihypertensive therapy for severe hypertension in pregnancy and postpartum: a systematic review.
    BJOG : an international journal of obstetrics and gynaecology, 2014, Volume: 121, Issue:10

    Topics: Administration, Oral; Antihypertensive Agents; Female; Humans; Hydralazine; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Postpartum Period; Pregnancy; Pregnancy Complications, Cardiovascular; Randomized Controlled Trials as Topic; Treatment Outcome; Vasodilator Agents

2014
New Evidence in the Management of Chronic Hypertension in Pregnancy.
    Seminars in nephrology, 2017, Volume: 37, Issue:4

    Topics: Algorithms; Antihypertensive Agents; Blood Pressure; Chronic Disease; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy; Randomized Controlled Trials as Topic

2017
Hypertension and Pregnancy: Management and Future Risks.
    Advances in chronic kidney disease, 2019, Volume: 26, Issue:2

    Topics: Antihypertensive Agents; Aspirin; Cardiovascular Diseases; Chronic Disease; Diuretics; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Platelet Aggregation Inhibitors; Pre-Eclampsia; Preconception Care; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care; Renal Insufficiency, Chronic; Risk Factors; Vasodilator Agents

2019
Pharmacokinetics of the most commonly used antihypertensive drugs throughout pregnancy methyldopa, labetalol, and nifedipine: a systematic review.
    European journal of clinical pharmacology, 2022, Volume: 78, Issue:11

    Topics: Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular

2022

Trials

21 trial(s) available for labetalol and methyldopa

ArticleYear
Labetalol, a cross-over double blind controlled trial.
    European journal of clinical pharmacology, 1978, Dec-18, Volume: 14, Issue:5

    Topics: Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Methyldopa; Placebos

1978
A comparative study of methyldopa and labetalol in the treatment of hypertension.
    British journal of clinical pharmacology, 1979, Volume: 8, Issue:Suppl 2

    Topics: Blood Cell Count; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Patient Compliance; Time Factors

1979
Use of labetalol and methyldopa in pregnancy-induced hypertension.
    British journal of clinical pharmacology, 1979, Volume: 8, Issue:Suppl 2

    Topics: Administration, Oral; Blood Pressure; Ethanolamines; Female; Humans; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Time Factors

1979
The short term effects of oral labetalol in patients with chronic renal disease and hypertension.
    Journal of human hypertension, 1992, Volume: 6, Issue:3

    Topics: Administration, Oral; Adult; Blood Pressure; Chronic Disease; Double-Blind Method; Female; Glomerular Filtration Rate; Humans; Hypertension; Kidney Diseases; Labetalol; Male; Methyldopa; Middle Aged; Renal Circulation; Time Factors

1992
A comparison of no medication versus methyldopa or labetalol in chronic hypertension during pregnancy.
    American journal of obstetrics and gynecology, 1990, Volume: 162, Issue:4

    Topics: Adult; Female; Humans; Hypertension; Infant Mortality; Infant, Newborn; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Randomized Controlled Trials as Topic

1990
Comparison of antihypertensive efficacy and perinatal safety of labetalol and methyldopa in the treatment of hypertension in pregnancy: a randomized controlled trial.
    British journal of obstetrics and gynaecology, 1988, Volume: 95, Issue:9

    Topics: Adult; Clinical Trials as Topic; Female; Fetal Death; Fetus; Hemodynamics; Humans; Hypertension; Infant, Newborn; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prenatal Care; Random Allocation; Respiration

1988
[Maternal effects and perinatal safety of labetalol in the treatment of hypertension in pregnancy. Comparison with methyldopa in a randomized cooperative trial].
    Archives des maladies du coeur et des vaisseaux, 1987, Volume: 80, Issue:6

    Topics: Adult; Clinical Trials as Topic; Female; Humans; Hypertension; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome; Random Allocation

1987
[Randomized, comparative study on the treatment of moderate arterial hypertension during pregnancy: methyldopa, acebutolol, labetalol].
    Archives des maladies du coeur et des vaisseaux, 1988, Volume: 81 Spec No

    Topics: Acebutolol; Adult; Female; Heart Rate, Fetal; Humans; Hypertension; Hypoglycemia; Infant, Newborn; Labetalol; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Prospective Studies; Random Allocation

1988
Treatment of severe hypertension with labetalol compared with methyldopa and furosemide. Results of a long-term, double-blind, multicenter trial.
    The American journal of medicine, 1983, Oct-17, Volume: 75, Issue:4A

    Topics: Adult; Aged; Blood Pressure; Clinical Trials as Topic; Double-Blind Method; Drug Therapy, Combination; Ethanolamines; Female; Furosemide; Humans; Hypertension; Labetalol; Male; Methyldopa; Middle Aged

1983
"Third drug" trial: comparative study of antihypertensive agents added to treatment when blood pressure remains uncontrolled by a beta blocker plus thiazide diuretic.
    British medical journal (Clinical research ed.), 1984, Jan-14, Volume: 288, Issue:6411

    Topics: Adolescent; Adult; Aged; Antihypertensive Agents; Atenolol; Bendroflumethiazide; Blood Pressure; Clinical Trials as Topic; Drug Administration Schedule; Drug Therapy, Combination; Female; Humans; Hydralazine; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Minoxidil; Prazosin

1984
A controlled comparison of the antihypertensive effects of labetalol and alpha-methyldopa.
    Pharmatherapeutica, 1982, Volume: 3, Issue:2

    Topics: Adult; Blood Pressure; Clinical Trials as Topic; Ethanolamines; Female; Heart Rate; Humans; Hypertension; Labetalol; Male; Methyldopa; Middle Aged

1982
Comparison of the alpha and beta blocking drug, labetalol, and methyl dopa in the treatment of moderate and severe pregnancy-induced hypertension.
    Clinical and experimental hypertension, 1980, Volume: 2, Issue:5

    Topics: Adult; Blood Pressure; Creatinine; Ethanolamines; Female; Fetus; Humans; Hydralazine; Hypertension; Labetalol; Labor, Obstetric; Metabolic Clearance Rate; Methyldopa; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular; Sodium; Uric Acid

1980
Labetalol vs. methyldopa in the treatment of pregnancy-induced hypertension.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1995, Volume: 49, Issue:2

    Topics: Adult; Blood Pressure; Cesarean Section; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Humans; Hypertension; Infant, Newborn; Kuwait; Labetalol; Labor, Induced; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular

1995
Effect of antihypertensive therapy in preeclampsia on levels of serum interleukin-4.
    Gynecologic and obstetric investigation, 1996, Volume: 42, Issue:4

    Topics: Adult; Antihypertensive Agents; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Infusions, Intravenous; Interleukin-4; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy

1996
Effect of L-arginine on blood pressure in pregnancy-induced hypertension: a randomized placebo-controlled trial.
    The journal of maternal-fetal & neonatal medicine : the official journal of the European Association of Perinatal Medicine, the Federation of Asia and Oceania Perinatal Societies, the International Society of Perinatal Obstetricians, 2006, Volume: 19, Issue:5

    Topics: Adolescent; Adult; Antihypertensive Agents; Arginine; Blood Pressure; Female; Gestational Age; Humans; Hypertension, Pregnancy-Induced; Infusions, Intravenous; Labetalol; Methyldopa; Middle Aged; Placebos; Pregnancy

2006
Role of antihypertensive therapy in mild to moderate pregnancy-induced hypertension: a prospective randomized study comparing labetalol with alpha methyldopa.
    Archives of gynecology and obstetrics, 2012, Volume: 285, Issue:6

    Topics: Adult; Antihypertensive Agents; Cesarean Section; Female; Humans; Hypertension, Pregnancy-Induced; Incidence; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Methyldopa; Pregnancy; Premature Birth; Proteinuria; Severity of Illness Index; Treatment Outcome; Young Adult

2012
Fetomaternal outcome in severe preeclamptic women undergoing emergency cesarean section under either general or spinal anesthesia.
    Journal of pregnancy, 2014, Volume: 2014

    Topics: Adolescent; Adult; Anesthesia, General; Anesthesia, Spinal; Anticonvulsants; Antihypertensive Agents; Apgar Score; Cesarean Section; Female; Fetal Mortality; Gestational Age; Humans; Infant, Newborn; Infant, Premature; Labetalol; Magnesium Sulfate; Maternal Mortality; Methyldopa; Pre-Eclampsia; Pregnancy; Premature Birth; Prospective Studies; Seizures; Severity of Illness Index; Treatment Outcome; Young Adult

2014
Control of Hypertension In Pregnancy Study randomised controlled trial-are the results dependent on the choice of labetalol or methyldopa?
    BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:7

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Clinical Decision-Making; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Low Birth Weight; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Premature Birth; Prenatal Care; Risk Factors; Treatment Outcome

2016
Do labetalol and methyldopa have different effects on pregnancy outcome? Analysis of data from the Control of Hypertension In Pregnancy Study (CHIPS) trial.
    BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:7

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Infant, Low Birth Weight; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Outcome

2016
Oral antihypertensive regimens (nifedipine retard, labetalol, and methyldopa) for management of severe hypertension in pregnancy: an open-label, randomised controlled trial.
    Lancet (London, England), 2019, Sep-21, Volume: 394, Issue:10203

    Topics: Administration, Oral; Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension, Pregnancy-Induced; India; Infant, Newborn; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Treatment Outcome; Young Adult

2019
Methyldopa versus labetalol or no medication for treatment of mild and moderate chronic hypertension during pregnancy: a randomized clinical trial.
    Hypertension in pregnancy, 2020, Volume: 39, Issue:4

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Humans; Hypertension; Labetalol; Methyldopa; Pregnancy; Treatment Outcome; Young Adult

2020

Other Studies

52 other study(ies) available for labetalol and methyldopa

ArticleYear
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
    Current drug discovery technologies, 2004, Volume: 1, Issue:4

    Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration

2004
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
    Drug metabolism and disposition: the biological fate of chemicals, 2008, Volume: 36, Issue:7

    Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding

2008
Quantitative structure-activity relationship and complex network approach to monoamine oxidase A and B inhibitors.
    Journal of medicinal chemistry, 2008, Nov-13, Volume: 51, Issue:21

    Topics: Computational Biology; Drug Design; Humans; Isoenzymes; Molecular Structure; Monoamine Oxidase; Monoamine Oxidase Inhibitors; Quantitative Structure-Activity Relationship

2008
Physicochemical determinants of human renal clearance.
    Journal of medicinal chemistry, 2009, Aug-13, Volume: 52, Issue:15

    Topics: Humans; Hydrogen Bonding; Hydrogen-Ion Concentration; Hydrophobic and Hydrophilic Interactions; Kidney; Metabolic Clearance Rate; Molecular Weight

2009
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
    Chemical research in toxicology, 2010, Volume: 23, Issue:1

    Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship

2010
Development of a phospholipidosis database and predictive quantitative structure-activity relationship (QSAR) models.
    Toxicology mechanisms and methods, 2008, Volume: 18, Issue:2-3

    Topics:

2008
Neural computational prediction of oral drug absorption based on CODES 2D descriptors.
    European journal of medicinal chemistry, 2010, Volume: 45, Issue:3

    Topics: Administration, Oral; Humans; Models, Chemical; Neural Networks, Computer; Permeability; Quantitative Structure-Activity Relationship; Technology, Pharmaceutical

2010
Multi-target spectral moment QSAR versus ANN for antiparasitic drugs against different parasite species.
    Bioorganic & medicinal chemistry, 2010, Mar-15, Volume: 18, Issue:6

    Topics: Antiparasitic Agents; Molecular Structure; Neural Networks, Computer; Parasitic Diseases; Quantitative Structure-Activity Relationship; Species Specificity; Thermodynamics

2010
Developing structure-activity relationships for the prediction of hepatotoxicity.
    Chemical research in toxicology, 2010, Jul-19, Volume: 23, Issue:7

    Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Humans; Structure-Activity Relationship; Tetracyclines; Thiophenes

2010
Predicting phospholipidosis using machine learning.
    Molecular pharmaceutics, 2010, Oct-04, Volume: 7, Issue:5

    Topics: Animals; Artificial Intelligence; Databases, Factual; Drug Discovery; Humans; Lipidoses; Models, Biological; Phospholipids; Support Vector Machine

2010
A predictive ligand-based Bayesian model for human drug-induced liver injury.
    Drug metabolism and disposition: the biological fate of chemicals, 2010, Volume: 38, Issue:12

    Topics: Bayes Theorem; Chemical and Drug Induced Liver Injury; Humans; Ligands

2010
Prediction of drug intestinal absorption by new linear and non-linear QSPR.
    European journal of medicinal chemistry, 2011, Volume: 46, Issue:1

    Topics: Humans; Intestinal Absorption; Linear Models; Molecular Conformation; Nonlinear Dynamics; Permeability; Pharmaceutical Preparations; Probability; Quantitative Structure-Activity Relationship; Thermodynamics

2011
QSAR-based permeability model for drug-like compounds.
    Bioorganic & medicinal chemistry, 2011, Apr-15, Volume: 19, Issue:8

    Topics: Caco-2 Cells; Cell Membrane Permeability; Drug Discovery; Humans; Pharmaceutical Preparations; Pharmacokinetics; Quantitative Structure-Activity Relationship

2011
FDA-approved drug labeling for the study of drug-induced liver injury.
    Drug discovery today, 2011, Volume: 16, Issue:15-16

    Topics: Animals; Benchmarking; Biomarkers, Pharmacological; Chemical and Drug Induced Liver Injury; Drug Design; Drug Labeling; Drug-Related Side Effects and Adverse Reactions; Humans; Pharmaceutical Preparations; Reproducibility of Results; United States; United States Food and Drug Administration

2011
Preclinical strategy to reduce clinical hepatotoxicity using in vitro bioactivation data for >200 compounds.
    Chemical research in toxicology, 2012, Oct-15, Volume: 25, Issue:10

    Topics: Chemical and Drug Induced Liver Injury; Cytochrome P-450 Enzyme Inhibitors; Cytochrome P-450 Enzyme System; Decision Trees; Drug Evaluation, Preclinical; Drug-Related Side Effects and Adverse Reactions; Glutathione; Humans; Liver; Pharmaceutical Preparations; Protein Binding

2012
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.
    Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

    Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012
Comparison of the accuracy of experimental and predicted pKa values of basic and acidic compounds.
    Pharmaceutical research, 2014, Volume: 31, Issue:4

    Topics: Chemistry, Pharmaceutical; Forecasting; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Random Allocation

2014
Treatment of severe and resistant hypertension.
    British journal of hospital medicine, 1978, Volume: 20, Issue:4

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Clonidine; Diazoxide; Diet, Sodium-Restricted; Diuretics; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroprusside; Patient Dropouts; Trimethaphan; Vasodilator Agents

1978
Labetalol in long-term treatment of hypertension.
    British journal of clinical pharmacology, 1976, Volume: 3, Issue:4 Suppl 3

    Topics: Adrenergic Agents; Adrenergic beta-Antagonists; Adult; Aged; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Evaluation; Ethanolamines; Female; Humans; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Posture

1976
HPLC of urinary catecholamines in the presence of labetalol, captopril, and alpha-methyldopa.
    Clinical chemistry, 1990, Volume: 36, Issue:10

    Topics: Adrenal Gland Neoplasms; Captopril; Catecholamines; Chromatography, High Pressure Liquid; False Positive Reactions; Humans; Labetalol; Methyldopa; Pheochromocytoma

1990
[Hypertension in pregnancy: proposed monitoring and therapy].
    Minerva ginecologica, 1985, Volume: 37, Issue:10

    Topics: Adrenergic beta-Antagonists; Captopril; Diuretics; Female; Follow-Up Studies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Prazosin; Pregnancy; Pregnancy Complications, Cardiovascular

1985
Baroreflex sensitivity alteration following transient hemispheric ischaemia in rats: protective effect of alphamethyldopa and guanfacine.
    Clinical and experimental pharmacology & physiology, 1986, Volume: 13, Issue:7

    Topics: Animals; Blood Pressure; Enalapril; Guanfacine; Guanidines; Heart Rate; Ischemic Attack, Transient; Labetalol; Male; Methyldopa; Nicardipine; Phenylacetates; Pressoreceptors; Rats; Rats, Inbred Strains; Reflex; Tachycardia

1986
Current concepts in treatment of hypertensive emergencies.
    American heart journal, 1986, Volume: 111, Issue:1

    Topics: Diazoxide; Drug Therapy, Combination; Emergencies; Humans; Hydralazine; Hypertension; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Phentolamine; Reserpine; Sympathomimetics; Trimethaphan; Vasodilator Agents

1986
Fetal haemodynamics before and after treatment of maternal hypertension in pregnancy.
    Danish medical bulletin, 1987, Volume: 34, Issue:3

    Topics: Blood Flow Velocity; Female; Fetus; Hemodynamics; Humans; Hypertension; Labetalol; Maternal-Fetal Exchange; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Trimester, Third; Ultrasonics

1987
Failure of anti-hypertensive drugs to control blood pressure rise with isometric exercise in hypertension.
    Postgraduate medical journal, 1981, Volume: 57, Issue:671

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Blood Pressure; Diuretics; Drug Therapy, Combination; Female; Humans; Hypertension; Isometric Contraction; Labetalol; Male; Methyldopa; Middle Aged; Physical Exertion; Pulse; Vasodilator Agents

1981
Hemodynamic effects of antihypertensive agents.
    Canadian Medical Association journal, 1983, Jan-01, Volume: 128, Issue:1

    Topics: Adolescent; Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Benzothiadiazines; Cardiac Output; Clonidine; Diuretics; Follow-Up Studies; Hemodynamics; Humans; Hypertension; Labetalol; Male; Methyldopa; Middle Aged; Risk; Sodium Chloride Symporter Inhibitors; Stroke Volume

1983
Antihypertensives and their impact on renal function.
    The American journal of medicine, 1983, Oct-17, Volume: 75, Issue:4A

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Captopril; Central Nervous System; Clonidine; Glomerular Filtration Rate; Humans; Kidney; Labetalol; Methyldopa; Prazosin; Renal Circulation; Vasodilator Agents

1983
Renin and aldosterone concentrations in pregnant essential hypertensives - a prospective study.
    Clinical and experimental hypertension. Part B, Hypertension in pregnancy, 1983, Volume: 2, Issue:2

    Topics: Adult; Aldosterone; Female; Humans; Hypertension; Labetalol; Methyldopa; Potassium; Pregnancy; Pregnancy Complications, Cardiovascular; Pregnancy Maintenance; Prospective Studies; Renin; Sodium

1983
Effects of labetalol and methyldopa on renal function.
    Clinical pharmacology and therapeutics, 1981, Volume: 30, Issue:1

    Topics: Adult; Aged; Double-Blind Method; Ethanolamines; Humans; Hypertension; Inulin; Kidney; Kidney Concentrating Ability; Labetalol; Male; Methyldopa; Middle Aged; p-Aminohippuric Acid; Vascular Resistance

1981
Angiotensin II maintains, but does not mediate, isoproterenol-induced cardiac hypertrophy in rats.
    The American journal of physiology, 1994, Volume: 267, Issue:4 Pt 2

    Topics: Actins; Angiotensin II; Animals; Base Sequence; Biphenyl Compounds; Blood Pressure; Captopril; Cardiomegaly; DNA; DNA Primers; Dose-Response Relationship, Drug; Gene Expression; Genes, fos; Heart; Hydralazine; Hydroxyproline; Imidazoles; Isoproterenol; Labetalol; Losartan; Male; Methyldopa; Molecular Sequence Data; Myocardium; Myosins; Polymerase Chain Reaction; Rats; Rats, Sprague-Dawley; RNA; RNA, Messenger; Tetrazoles; Transcription, Genetic

1994
Intravenous antihypertensive agents for patients unable to take oral medications.
    American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists, 1995, Jul-15, Volume: 52, Issue:14

    Topics: Adrenergic beta-Antagonists; Antihypertensive Agents; Calcium Channel Blockers; Enalaprilat; Furosemide; Humans; Hydralazine; Hypertension; Injections, Intravenous; Labetalol; Methyldopa; Nitroglycerin; Nitroprusside; Vasodilator Agents

1995
Heart rate and heart rate variability during sleep in small-for-gestational age newborns.
    Pediatric research, 1994, Volume: 35, Issue:4 Pt 1

    Topics: Basal Metabolism; Birth Weight; Female; Fetal Growth Retardation; Gestational Age; Heart Rate; Humans; Hypertension; Infant, Newborn; Infant, Small for Gestational Age; Labetalol; Male; Methyldopa; Pregnancy; Pregnancy Complications, Cardiovascular; Sleep

1994
Recurrent cholestasis following ovarian hyperstimulation syndrome: case report.
    Human reproduction (Oxford, England), 1999, Volume: 14, Issue:9

    Topics: Adult; Antihypertensive Agents; Cesarean Section; Cholestasis; Female; Fertilization in Vitro; Gestational Age; Humans; Labetalol; Liver Function Tests; Methyldopa; Ovarian Hyperstimulation Syndrome; Pregnancy; Pregnancy Complications; Pregnancy, Multiple; Recurrence; Twins

1999
Guidelines on high blood pressure in pregnancy give new classifications of disease.
    Report on medical guidelines & outcomes research, 2000, Dec-18, Volume: 11, Issue:24

    Topics: Adrenergic alpha-Antagonists; Adrenergic beta-Antagonists; Antihypertensive Agents; Atenolol; Contraindications; Female; Humans; Hypertension; Labetalol; Methyldopa; Practice Guidelines as Topic; Pre-Eclampsia; Pregnancy; United States

2000
Anti-hypertensive therapy and the feto-placental circulation: effects on umbilical artery resistance.
    Journal of perinatal medicine, 2004, Volume: 32, Issue:4

    Topics: Adult; Antihypertensive Agents; Dose-Response Relationship, Drug; Female; Fetus; Humans; Hydralazine; Labetalol; Magnesium Sulfate; Methyldopa; Nifedipine; Placenta; Pre-Eclampsia; Pregnancy; Regional Blood Flow; Umbilical Arteries; Vascular Resistance

2004
Management of Takayasu arteritis during pregnancy.
    Journal of clinical hypertension (Greenwich, Conn.), 2009, Volume: 11, Issue:7

    Topics: Adult; Angiography; Antihypertensive Agents; Cesarean Section; Diagnosis, Differential; Female; Glucocorticoids; Humans; Labetalol; Lisinopril; Magnetic Resonance Imaging; Methyldopa; Pre-Eclampsia; Prednisone; Pregnancy; Pregnancy Complications, Cardiovascular; Takayasu Arteritis; Tomography, X-Ray Computed; Ultrasonography, Doppler, Duplex

2009
Is expectant management of early-onset severe preeclampsia worthwhile in low-resource settings?
    Archives of gynecology and obstetrics, 2010, Volume: 282, Issue:1

    Topics: Adolescent; Adult; Antihypertensive Agents; Egypt; Female; Fetal Death; Fetal Monitoring; Gestational Age; Glucocorticoids; Hospitals, Teaching; Humans; Infant, Newborn; Labetalol; Length of Stay; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Outcome; Pregnancy Trimester, Second; Pregnancy Trimester, Third; Prospective Studies; Risk Factors; Young Adult

2010
Antihypertensive treatment during pregnancy and functional development at primary school age in a historical cohort study.
    BJOG : an international journal of obstetrics and gynaecology, 2010, Volume: 117, Issue:9

    Topics: Antihypertensive Agents; Attention; Attention Deficit Disorder with Hyperactivity; Bed Rest; Child; Child Development; Child, Preschool; Female; Humans; Hypertension, Pregnancy-Induced; Intelligence; Labetalol; Methyldopa; Netherlands; Pregnancy; Prenatal Exposure Delayed Effects; Psychomotor Performance; Schools

2010
[HTA-pre-eclampsia-postpartum haemolytic-uraemic syndrome: good results can be achieved].
    Nefrologia : publicacion oficial de la Sociedad Espanola Nefrologia, 2010, Volume: 30, Issue:5

    Topics: Adult; Angiotensin II Type 1 Receptor Blockers; Anti-Inflammatory Agents; Antihypertensive Agents; Cesarean Section; Combined Modality Therapy; Emergencies; Female; Hemolytic-Uremic Syndrome; Humans; Hypertension; Labetalol; Methyldopa; Plasmapheresis; Pre-Eclampsia; Prednisone; Pregnancy; Puerperal Disorders; Remission Induction

2010
A case of hypertension with virilisation during pregnancy.
    The Australian & New Zealand journal of obstetrics & gynaecology, 2010, Volume: 50, Issue:6

    Topics: Adult; Aspirin; Brenner Tumor; Calcium; Cesarean Section; Dehydroepiandrosterone Sulfate; Dietary Supplements; Estradiol; Fatty Acids, Omega-3; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Multiple Sclerosis; Ovarian Neoplasms; Pregnancy; Pregnancy Complications, Neoplastic; Progesterone; Steroids; Testosterone; Treatment Outcome; Virilism

2010
Outpatient calcium-channel blockers and the risk of postpartum haemorrhage: a cohort study.
    BJOG : an international journal of obstetrics and gynaecology, 2013, Volume: 120, Issue:13

    Topics: Adolescent; Adult; Antihypertensive Agents; Calcium Channel Blockers; Cohort Studies; Female; Humans; Hypertension; Labetalol; Medicaid; Methyldopa; Postpartum Hemorrhage; Pregnancy; Propensity Score; Risk Assessment; United States; Uterine Inertia; Young Adult

2013
Trends in using beta-blockers and methyldopa for hypertensive disorders during pregnancy in a Canadian population.
    European journal of obstetrics, gynecology, and reproductive biology, 2013, Volume: 171, Issue:2

    Topics: Adrenergic beta-Antagonists; Adult; Antihypertensive Agents; Female; Humans; Hypertension; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Pre-Eclampsia; Pregnancy; Pregnancy Complications, Cardiovascular; Saskatchewan

2013
Association between labetalol use for hypertension in pregnancy and adverse infant outcomes.
    European journal of obstetrics, gynecology, and reproductive biology, 2014, Volume: 175

    Topics: Adult; Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Methyldopa; Pregnancy; Retrospective Studies

2014
Antihypertensive drugs methyldopa, labetalol, hydralazine, and clonidine improve trophoblast interaction with endothelial cellular networks in vitro.
    Journal of hypertension, 2014, Volume: 32, Issue:5

    Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Cytokines; Endothelium, Vascular; Female; Humans; Hydralazine; In Vitro Techniques; Labetalol; Methyldopa; Trophoblasts

2014
In-vitro study of the effect of anti-hypertensive drugs on placental hormones and angiogenic proteins synthesis in pre-eclampsia.
    PloS one, 2014, Volume: 9, Issue:9

    Topics: Activins; Angiogenic Proteins; Antigens, CD; Antihypertensive Agents; Chorionic Gonadotropin; Chorionic Villi; Dose-Response Relationship, Drug; Endoglin; Enzyme-Linked Immunosorbent Assay; Female; Humans; Hydralazine; Labetalol; Methyldopa; Placenta; Placental Hormones; Pravastatin; Pre-Eclampsia; Pregnancy; Receptors, Cell Surface; Time Factors; Tissue Culture Techniques; Vascular Endothelial Growth Factor Receptor-1

2014
The benefits/risks of treatment of non-severe hypertension in pregnancy and choice of drug remain unanswered.
    BJOG : an international journal of obstetrics and gynaecology, 2016, Volume: 123, Issue:7

    Topics: Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Methyldopa; Pregnancy; Risk Assessment

2016
Antihypertensive methyldopa, labetalol, hydralazine, and clonidine reversed tumour necrosis factor-α inhibited endothelial nitric oxide synthase expression in endothelial-trophoblast cellular networks.
    Clinical and experimental pharmacology & physiology, 2017, Volume: 44, Issue:3

    Topics: Antihypertensive Agents; Cells, Cultured; Clonidine; Coculture Techniques; Culture Media, Conditioned; Endothelial Cells; Endothelium, Vascular; Female; Humans; Hydralazine; Interleukin-1 Receptor-Like 1 Protein; Labetalol; Methyldopa; Nitric Oxide Synthase Type III; Trophoblasts; Tumor Necrosis Factor-alpha; Uterus

2017
Oral regimen management of acute hypertension in pregnancy.
    Lancet (London, England), 2019, 09-21, Volume: 394, Issue:10203

    Topics: Antihypertensive Agents; Female; Humans; Hypertension; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Complications, Cardiovascular

2019
Applications of shun shell column and nanocomposite sorbent for analysis of eleven anti-hypertensive in human plasma.
    Journal of chromatography. B, Analytical technologies in the biomedical and life sciences, 2020, Jun-01, Volume: 1146

    Topics: Adsorption; Antihypertensive Agents; Chromatography, High Pressure Liquid; Diltiazem; Furosemide; Humans; Hydrochlorothiazide; Irbesartan; Iron; Labetalol; Limit of Detection; Losartan; Metal Nanoparticles; Methyldopa; Nanocomposites; Polyvinyl Alcohol; Prazosin; Propranolol; Reproducibility of Results; Solid Phase Microextraction; Spironolactone; Valsartan

2020
Preventing Recurrent Preeclampsia by Tailored Treatment of Nonphysiologic Hemodynamic Adjustments to Pregnancy.
    Hypertension (Dallas, Tex. : 1979), 2021, Volume: 77, Issue:6

    Topics: Adult; Antihypertensive Agents; Blood Pressure; Female; Hemodynamics; Humans; Labetalol; Methyldopa; Nifedipine; Pre-Eclampsia; Pregnancy; Secondary Prevention

2021
Which antihypertensive treatment is better for mild to moderate hypertension in pregnancy?
    BMJ (Clinical research ed.), 2022, 01-18, Volume: 376

    Topics: Antihypertensive Agents; Female; Humans; Hypertension, Pregnancy-Induced; Labetalol; Methyldopa; Nifedipine; Pregnancy; Prenatal Care; Treatment Outcome

2022
Maternal and neonatal outcomes of antihypertensive treatment in pregnancy: A retrospective cohort study.
    PloS one, 2022, Volume: 17, Issue:5

    Topics: Antihypertensive Agents; Birth Weight; Female; Humans; Hypertension, Pregnancy-Induced; Infant; Infant, Newborn; Infant, Newborn, Diseases; Labetalol; Methyldopa; Nifedipine; Pregnancy; Pregnancy Outcome; Premature Birth; Retrospective Studies

2022